American Heart Association (heart.org).
4
Hidden in Plain Sight // SugarScience, University of California at San Francisco // sugarscience.ucsf.edu/hidden-in-plain-sight/.
5
Haig A. Uric Acid as a Factor in the Causation of Disease: A Contribution to the Pathology of High Arterial Tension, Headache, Epilepsy, Mental Depression, Paroxysmal Hæmoglobinuria and Anæmia, Bright’s Disease, Diabetes, Gout, Rheumatism, and Other Disorders. London: Franklin Classics, 2018. См. также Haig A. Uric Acid as a Factor in the Causation of Disease – A Contribution to the Pathology of High Blood Pressure, Headache, Epilepsy, Mental Depression, Paroxysmal Hemoglobinuria and Anemia, Bright’s Disease, Gout, Rheumatism and other Disorders // JAMA. 1898. Vol. 31. № 3. P. 139 // doi.org/10.1001/jama.1898.02450030041022.
6
Fragkou Th., Goula K., Drakoulogkona O. The History of Gout Through Centuries // Nephrology Dialysis Transplantation. 2015. May. Vol. 30. Suppl. 3. Pp. iii377–iii380 // doi.org/10.1093/ndt/gfv186.05.
7
Oxford English Dictionary, 2nd ed. Oxford, UK: Oxford University Press, 2004.
8
Nuki G., Simkin P. A. A Concise History of Gout and Hyperuricemia and Their Treatment // Arthritis Research & Therapy. 2006. Vol. 8. Suppl. 1. P. S1 // doi.org/10.1186/ar1906.
9
Maurer J. Early Gout Is Bad for the Heart: Recent Research Context // Med-Page Today, November 28, 2019 // medpagetoday.com/reading-room/acrr/generalrheumatology/83581. См. также Li Y. et al. Clinical Characteristics of Early-Onset Gout in Outpatient Setting // ACR Open Rheumatology. 2019. Vol. 1. № 7. Pp. 397–402 // doi.org/10.1002/acr2.11057.
10
Singh J. A. Gout: Will the “King of Diseases” Be the First Rheumatic Disease to Be Cured? // BMC Medicine. 2016. Vol. 14. P. 180 // doi.org/10.1186/s12916-016-0732-1.
11
George Ch., Minter D. A. Hyperuricemia // StatPearls. Treasure Island, FL: 2021 // ncbi.nlm.nih.gov/books/NBK459218/.
12
Chen J.-H. et al. Serum Uric Acid Level as an Independent Risk Factor for All-Cause, Cardiovascular, and Ischemic Stroke Mortality: A Chinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol. 61. № 2. Pp. 225–232 // doi.org/10.1002/art.24164. См. также Prado de Oliveira E., Burini R. C. High Plasma Uric Acid Concentration: Causes and Consequences // Diabetology & Metabolic Syndrome. 2012. April. Vol. 4. P. 12 // doi.org/10.1186/1758-5996-4-12.
13
El Ridi R., Tallima H. Physiological Functions and Pathogenic Potential of Uric Acid: A Review // Journal of Advanced Research. 2017. September. Vol. 8. № 5. Pp. 487–493 // doi.org/10.1016/j.jare.2017.03.003.
14
El Ridi and Tallima, Physiological Functions and Pathogenic Potential of Uric Acid.
15
DiNicolantonio J. J., O’Keefe J. H., Lucan S. C. Added Fructose: A Principal Driver of Type 2 Diabetes Mellitus and Its Consequences // Mayo Clinic Proceedings. 2015. March. Vol. 90. № 3. Pp. 372–381 // doi.org/10.1016/j.mayocp.2014.12.019.
16
Stirpe F. et al. Fructose-induced Hyperuricaemia // The Lancet. 1970. December. Vol. 296. № 7686. Pp. 1310–1311 // doi.org/10.1016/s0140-6736(70)92269-5.
17
Goran M. I. et al. The Obesogenic Effect of High Fructose Exposure During Early Development // Nature Reviews Endocrinology. 2013. August. Vol. 9. № 8. Pp. 494–500.
18
Rivard Ch. et al. Sack and Sugar, and the Aetiology of Gout in England Between 1650 and 1900 // Rheumatology. 2013. March. Vol. 52. № 3. Pp. 421–426 // doi.org/10.1093/rheumatology/kes297.
19
Zgaga L. et al. The Association of Dietary Intake of Purine-Rich Vegetables, Sugar-Sweetened Beverages and Dairy with Plasma Urate, in a Cross-Sectional Study // PLOS ONE. 2012. Vol. 7. № 6. P. e38123 // doi.org/10.1371/journal.pone.0038123.
20
Singh J. A., Reddy S. G., Kundukulam J. Risk Factors for Gout and Prevention: A Systematic Review of the Literature // Current Opinion in Rheumatology. 2011. March. Vol. 23. № 2. Pp. 192–202 // doi.org/10.1097/BOR.0b013e3283438e13.
21
LUV созвучно английскому слову love (любовь). Прим. пер.
22
Выражение автора, означающее, что мочевая кислота разрушает организм, как бомба. Прим. пер.
23
Enzinger Ch. et al. Risk Factors for Progression of Brain Atrophy in Aging: Six-Year Follow-Up of Normal Subjects // Neurology. 2005. May 24. Vol. 64. № 10. Pp. 1704–1711 // doi.org/10.1212/01.WNL.0000161871.83614.BB.
